Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.193,17
0,28%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Waverley Pharma Inc (WAVE) Waverley Pharma Inc (WAVE) Notizie

WAVE

Waverley Pharma (WAVE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:WAVE
DataOraFonteTitoloSimboloCompagnia
01/05/202402:08PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
22/11/202323:00PR Newswire (Canada)Waverley Pharma Announces Changes to Board of DirectorsTSXV:WAVEWaverley Pharma Inc
20/03/202312:55PR Newswire (Canada)Waverley Pharma Provides Business UpdateTSXV:WAVEWaverley Pharma Inc
11/01/202313:55PR Newswire (Canada)Waverley Pharma Provides Update on its PARP-1 Inhibitor ProgramTSXV:WAVEWaverley Pharma Inc
05/08/202114:05PR Newswire (Canada)Waverley Pharma Announces $3,000,000 Credit FacilityTSXV:WAVEWaverley Pharma Inc
27/05/202114:05PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS EnglandTSXV:WAVEWaverley Pharma Inc
18/01/202114:40PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS ScotlandTSXV:WAVEWaverley Pharma Inc
12/11/202018:04PR Newswire (Canada)Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United StatesTSXV:WAVEWaverley Pharma Inc
23/09/202014:20PR Newswire (Canada)Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)TSXV:WAVEWaverley Pharma Inc
08/09/202016:13PR Newswire (Canada)Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...TSXV:WAVEWaverley Pharma Inc
25/08/202014:15PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in ItalyTSXV:WAVEWaverley Pharma Inc
30/07/202014:25PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European CountriesTSXV:WAVEWaverley Pharma Inc
25/06/202014:15PR Newswire (Canada)Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...TSXV:WAVEWaverley Pharma Inc
28/04/202022:53PR Newswire (Canada)Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial StatementsTSXV:WAVEWaverley Pharma Inc
03/02/202014:15PR Newswire (Canada)Waverley Pharma Announces Appointment of New President and CEOTSXV:WAVEWaverley Pharma Inc
08/01/202023:09PR Newswire (Canada)Waverley Pharma Announces Executive Leadership ChangesTSXV:WAVEWaverley Pharma Inc
17/12/201914:00PR Newswire (Canada)Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for ErlotinibTSXV:WAVEWaverley Pharma Inc
11/03/201913:25PR Newswire (Canada)Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary RevenueTSXV:WAVEWaverley Pharma Inc
18/12/201814:25PR Newswire (Canada)Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United KingdomTSXV:WAVEWaverley Pharma Inc
23/07/201814:35PR Newswire (Canada)Waverley Pharma Announces Resignation of CEO and Appointment of New CEOTSXV:WAVEWaverley Pharma Inc
27/06/201814:35PR Newswire (Canada)Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United StatesTSXV:WAVEWaverley Pharma Inc
25/06/201814:30PR Newswire (Canada)Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United KingdomTSXV:WAVEWaverley Pharma Inc
17/04/201814:30PR Newswire (Canada)Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
12/03/201814:00PR Newswire (Canada)Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
27/10/201716:01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)TSXV:WAVEWaverley Pharma Inc
27/10/201715:59PR Newswire (Canada)IIROC Trading Resumption - WAVE (Formerly BUFF.P)TSXV:WAVEWaverley Pharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:WAVE

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network